There are an estimated several million crack-cocaine users globally; use is highest in the
Americas. Most crack users are socio-economically marginalized (eg, homeless), and …

Background Cocaine is a psychostimulant used by approximately 0.4% of the general
population worldwide. Cocaine dependence is a chronic mental disorder characterised by …

Aims To estimate pooled all‐cause and cause‐specific mortality risk for people with regular
or problematic cocaine use. Methods Systematic review and meta‐analysis of prospective or …

Background Cocaine use disorder (CUD) remains a substantial public health problem with
no clearly effective pharmacotherapy available. In a prior trial, combined amphetamine and …

Background Cocaine use disorder (CUD) is a significant public health issue for which there
is no Food and Drug Administration-approved pharmacotherapy. Depressive disorders are …

Abstract Lorcaserin (Lorqess, Belviq®) is a selective 5-HT 2C receptor agonist that has
received FDA approval for the treatment of obesity. 5-HT 2C receptor agonists are also …

Abstract Treatment of psychostimulant addiction has been a major, and not fully met,
challenge. For opioid addiction, there is strong evidence for the effectiveness of several …

Cocaine addiction is a persistent and insidious public health problem (Pomara et al, 2012).
Despite evidence for sustained prevalence, clinical harm, and demand for treatment, the …

Background Cocaine misuse is a disorder for which no pharmacological treatment of proven
efficacy exists. Advances in neurobiology could guide future medication development …

Substance use in older HIV-infected patients : Current Opinion in HIV and AIDS Substance
use in older HIV-infected patients : Current Opinion in HIV and AIDS Log in or Register …